$GBCS

SELECTIS HEALTH, INC. (GBCS): Completion of Acquisition or Disposition of Assets

SELECTIS HEALTH, INC. (GBCS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Exhibit 99.1 PRESS RELEASE BLACK PEARL COMPLETES TENDER OFFER FOR ALL OUTSTANDING SHARES OF SELECTIS HEALTH, INC. New York, NY – September 1, 2026 — Black Pearl Equities, a New York-based investment group (together with its affiliates, “Black Pearl”), announced today that it has

Original reporting
Published Sep 9, 2026, 1:36 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 9, 2026, 10:05 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$GBCS
Bullish
high confidence
Mentioned
$GBCS
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GBCSBullishMed
01

Why it matters

The acquisition provides immediate liquidity to shareholders and may trigger delisting of GBCS from OTCQB, affecting liquidity and market access.

02

Market read

The deal is a material event for GBCS shareholders and may influence other small‑cap healthcare operators.

03

What to watch

Potential regulatory scrutiny of the merger and the impact on existing debt covenants were not detailed.

Relevance 7/10Novelty 6/10Timing: post‑tender completion (early September 2026)

Background

Selectis Health operates skilled nursing and assisted‑living facilities in the Southern U.S. and was the target of a cash tender offer by Black Pearl Equities.

Company-level read

Ticker impact

$GBCSBullishHigh confidence
Context

Black Pearl completed its tender offer for Selectis Health, acquiring ~90.9% of shares at $5.75 cash per share, leading to a cash-out merger.

Expected impact

Share price should converge to $5.75 and may rise slightly on the news before delisting.

Evidence & confidence

The tender offer is fully satisfied and the merger will close without a shareholder vote, delivering a known cash amount to holders.

Market effects

Consolidation in the senior‑care facilities sector may pressure peer valuations.

Limited to U.S. OTC market; minimal broader regional effect.

Low; the deal is micro‑cap and sector‑specific.

Counterpoint

If the integration risks materialize, the cash payout may be insufficient, and the stock could underperform the tender price.

Key entities

  • Selectis Health, Inc.

    OTCQB‑listed senior‑care operator being acquired.

  • Black Pearl Equities

    Acquirer completing the tender offer.

Related articles

$GBCSMed

SELECTIS HEALTH, INC. (GBCS): Completion of Acquisition or Disposition of Assets

SELECTIS HEALTH, INC. (GBCS) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01. Completion of Acquisition or Disposition of Assets. The information set forth in the Introductory Note and under Items 2.03, 3.03, 5.01, 5.02 and 5.03 of this Current Report on Form 8-K is incorporated herein by reference. At the Effective Time, each Share issued and o

$SPCXMed

SpaceX (SPCX) Plans $8 Billion Spectrum Buy to Expand Wireless R

SpaceX (SPCX) plans to acquire 800 MHz spectrum licenses for $8B to expand Starlink into mobile phone markets. Pivotal Research raised its price target to $230, implying 55% upside. SPCX has a high P/S ratio of 171.9x and a GF Score of 15/100, indicating growth potential but profitability challenges. Insiders sold $53.7M, while institutional investors added shares.

$KRHighAI 9/10

Senator raises concerns over Kroger’s plan to buy Giant Eagle

Sen. Elizabeth Warren expressed concerns over Kroger's $1.65B acquisition of Giant Eagle, citing potential harm to competition and consumers. She urged the FTC and DOJ to scrutinize the deal, along with two other proposed mergers in the food industry. Kroger plans to divest some stores to secure regulatory approval, according to antitrust experts.